Oxidative DNA damage induced by high glucose and its suppression in human umbilical vein endothelial cells.

In order to investigate the mechanism of the production of oxidative DNA damage by hyperglycemia, we measured formamidopyrimidine N-glycosylase (FPG)-sensitive sites by the comet assay in human umbilical vein endothelial cells (HUVECs) cultured under various conditions including high glucose. Mean values of FPG-sensitive sites were higher in HUVECs cultured for 5 days in high glucose (45 mM) compared with normal glucose (5mM) medium (P<0.001). FPG-sensitive sites increased in a time-dependent manner under high glucose treatment (3 days: P<0.05, 5 days: P<0.001), whereas L-glucose, which is taken up poorly into the cells, gave a slight increase in FPG-sensitive sites (P<0.05). Flow cytometric analysis using 6-carboxy-2',7'-dichlorodihydrofluorescein diacetate, di(acetoxymethyl ester) showed that incubation with L-glucose produced more reactive oxygen species than incubation with D-glucose. However, these increases were slight (1.22- and 1.12-folds, respectively). Incubation of HUVECs with aminoguanidine (100 microM) or pyridoxamine (1mM), which are inhibitors of glycation, decreased the levels of FPG-sensitive sites (P<0.001). However, these inhibitors did not suppress the intracellular generation of reactive oxygen species induced by high glucose. These results indicate that FPG-sensitive sites induced by high glucose are not due to intracellular reactive oxygen species. In order to clarify what caused the induction of FPG-sensitive sites, we investigated the effect of glyoxal and 3-deoxyglucosone (3-DG) on the induction of FPG-sensitive sites and the intracellular production of reactive oxygen species in HUVECs. Glyoxal and 3-DG at a concentration of 100 microg/ml induced FPG-sensitive sites (P<0.001, P<0.01, respectively). In contrast, glyoxal did not generate reactive oxygen species inside HUVECs. The results shown in this study suggest that glyoxal formed intracellularly or extracellularly during high glucose treatment might induce FPG-sensitive sites by a mechanism not involving reactive oxygen species.

[1]  R. Lobb,et al.  Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. , 1984, Biochemistry.

[2]  I. Antoshechkin,et al.  Substrate specificity of Fpg protein. Recognition and cleavage of oxidatively damaged DNA. , 1994, The Journal of biological chemistry.

[3]  T. Nicotera,et al.  Oxidative damage to DNA in diabetes mellitus , 1996, The Lancet.

[4]  I. Antoshechkin,et al.  Substrate Specificity of Fpg Protein , 1994 .

[5]  A. Collins,et al.  DNA damage in diabetes: correlation with a clinical marker. , 1998, Free radical biology & medicine.

[6]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[7]  U. Frei,et al.  Effect of glucose degradation products on human peritoneal mesothelial cell function. , 2000, Journal of the American Society of Nephrology : JASN.

[8]  H. Aburatani,et al.  Distinct Repair Activities of Human 7,8-Dihydro-8-oxoguanine DNA Glycosylase and Formamidopyrimidine DNA Glycosylase for Formamidopyrimidine and 7,8-Dihydro-8-oxoguanine* , 2000, The Journal of Biological Chemistry.

[9]  G. Spiteller,et al.  Previously unknown aldehydic lipid peroxidation compounds of arachidonic acid. , 1996, Chemistry and physics of lipids.

[10]  A. Booth,et al.  Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine. , 1996, Biochemical and biophysical research communications.

[11]  M. Namiki,et al.  A New Mechanism of the Maillard Reaction Involving Sugar Fragmentation and Free Radical Formation , 1983 .

[12]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[13]  R. Shapiro,et al.  On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines. A new synthesis of N2-alkylguanines. , 1969, Biochemistry.

[14]  P. Clingen,et al.  Induction of mutagenic DNA damage in human fibroblasts after exposure to artificial tanning lamps , 1997, The British journal of dermatology.

[15]  J. Baynes,et al.  Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. , 1995, Biochemistry.

[16]  Y. Nakamura,et al.  Bio-antimutagenic activities of vitamin B6 in E. coli and mouse peripheral blood cells. , 1992, Mutation research.

[17]  T. Shultz,et al.  Evaluation of cancer patient leukocyte responses in the presence of physiologic and pharmacologic pyridoxine and pyridoxal levels , 1989, Journal of clinical laboratory analysis.

[18]  A. Collins,et al.  Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. , 1993, Carcinogenesis.